Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
Clinical trial NCT04456413 · TERMINATED
Trial details
- NCT number
- NCT04456413
- Sponsor
- Hackensack Meridian Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-06
- Primary completion
- 2021-04-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.